Dermata Therapeutics Inc. (DRMA)
NASDAQ: DRMAHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 8, 4:00 PM ET · Delayed 15 min
DRMA stock chart
Technical analysisKey statistics
All statistics- Market cap
- $5.30M
- EPS (TTM)
- -$4.39
- Dividend yield
- None
- 52-week range
- 0.951 – 4.84
- Day range
- 1.06 – 1.07
- Volume / Avg
- 6.80K / 708.18K
- Beta
- —
- Shares outstanding
- 4.96M
52-week range
DRMA stock today
On Oct 8, DRMA ended the session at $1.07, shedding $0.05 (4.46%), versus the S&P 500's 0.47% decline. Trading was light, with 6.80K shares changing hands, about 1% of the average daily volume. At this level, DRMA sits near the bottom of its 52-week range of $0.951 to $4.84: 77.9% below the high and 12.5% above the low.
Dermata Therapeutics has posted a net loss over the last twelve months (EPS of -$4.39), so its P/E ratio is not meaningful.
Summary generated from market data by MetaCap's automated system. Methodology
About Dermata Therapeutics
Company profile- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- Headquarters
- San Diego, CA
- IPO year
- 2021
Dermata Therapeutics peers
Health Care sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| PULMPulmatrix Inc. | 1.53 | +2.49% | $5.58M | vs DRMA |
| ADXNAddex Therapeutics Ltd ADR | 3.18 | +6.81% | $5.57M | vs DRMA |
| ENLVEnlivex Ltd. | 0.277 | -10.85% | $5.51M | vs DRMA |
| KALAKALA BIO Inc. | 0.2966 | -17.61% | $5.74M | vs DRMA |
| BGMSBio Green Med Solution Inc. | 0.821 | -3.41% | $5.44M | vs DRMA |
| GELSGelteq Limited | 0.5488 | -1.98% | $5.88M | vs DRMA |
| IMNNImunon Inc. | 1.07 | -4.46% | $6.00M | vs DRMA |
| RDHLRedhill Biopharma Ltd. ADR | 0.578 | +21.94% | $5.14M | vs DRMA |
Indexes, lists and sector
Dermata Therapeutics stock FAQ
What is Dermata Therapeutics's stock price today?
DRMA last traded at $1.07 as of Oct 8, 4:00 PM EDT, down 4.46% on the day. Prices are delayed at least 15 minutes.
What is the DRMA 52-week high?
The 52-week high for DRMA is $4.84 and the 52-week low is $0.951. The stock is currently 77.9% below its high.